5-Amino-1MQ is a synthetic small-molecule inhibitor of nicotinamide N-methyltransferase studied for metabolic regulation and muscle physiology. While roden
Read more 5-Amino-1MQ: Preclinical Evidence, Translational Hurdles, and Research Gaps
Mazdutide (IBI362) is a dual GLP-1 and glucagon receptor co-agonist evaluated in Phase 2 and Phase 3 clinical trials. This evidence review examines publish
Read more Mazdutide Clinical Trials: Human Evidence, Efficacy, and Metabolic Outcomes
Retatrutide clinical trials evaluate a novel triple-hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors. Phase 2 and Phase 3 data demonst
Read more Retatrutide Clinical Trials: Human Evidence, Efficacy, and Safety Findings
A structured Minto Pyramid analysis of Mazdutide (IBI362), detailing its dual GLP-1 and glucagon receptor agonism, glycemic and weight regulation, and hepa
A comprehensive review of MOTS-c peptide research, evaluating its cellular signaling mechanisms, preclinical metabolic findings, and current clinical statu
Read more MOTS-c Peptide: Mechanisms, Preclinical Evidence, and Clinical Translation
An evidence-based scientific overview of Mazdutide (IBI362), evaluating its dual GLP-1 and glucagon receptor co-agonism across in-vitro, preclinical, and h
Survodutide is a dual GLP-1 and glucagon receptor agonist demonstrating potent efficacy across clinical trials for obesity, metabolic dysfunction, and stea
A comprehensive scientific evaluation of Eloralintide (LY3849891), an investigational long-acting amylin receptor agonist evaluated for weight management a
Read more Eloralintide Research Peptide: Mechanisms, Clinical Data, and Pharmacological Profile
A structured Minto Pyramid review examining tirzepatide’s pharmacology, evidence hierarchy, and dual GIP/GLP-1 receptor agonism in metabolic and endocrine
A comprehensive scientific overview of semaglutide using the Minto Pyramid framework, examining its structural stability, receptor pharmacology, and eviden